Supporting a tumor suppressive function, Kdm5c-KD resulted in a profound enrichment (19-32 fold) of cells expressing Kdm5c-targeting shRNAs compared to control AML cells (Fig. 1E). Here, KDM5C is linked to acute myeloid leukemia.